With the market in considerable turbulence, ASX shares that pay out dividends seem to be back in favour.
They were out of fashion for much of the pandemic as businesses tightened their belts to preserve capital.
But now investors are looking to ASX shares with chunky yields as a buffer from tough market and economic conditions.
“We liken an attractive yield to being ‘paid to play’ while we wait for market conditions to improve,” Celeste Funds executive chair Paul Biddle told the Australian Financial Review.
“That’s not a bad outcome if the sharemarket is flat this year.”
Keeping this in mind, another prominent fund manager this week revealed which dividend stock he has picked up in recent times — and another that he has cut loose:
‘Very attractive dividend yield’
Blackmore Capital chief investment officer Marcus Bogdan said that his fund recently bought shares in Atlas Arteria Group (ASX: ALX).
“We’re allocating capital to Atlas Arteria, which is a toll road operator in both Europe and the US,” he told Switzer TV Investing.
“It provides a very attractive dividend yield for our investors.”
Indeed, Atlas Arteria shares are handing out a dividend yield of 5.16% while its stock price holds steady this year.
The analyst community generally agrees with Bogdan.
According to CMC Markets, six out of 11 analysts rate the stock as a strong buy, with another labelling it as a moderate buy.
Last month, Atlas Funds Management chief investment officer Hugh Dive told The Motley Fool that his fund had also been “buying a lot” of Atlas Arteria stocks.
“That bounced back much faster than we expected when the lockdowns were opened in France,” he said.
“Has extremely low cost of debt. Great set of assets. Dividends are growing quite strongly.”
The dividend share that’s reached ‘peak earnings’
Meanwhile, Bogdan’s team recently sold off their interest in another dividend share, Healius Ltd (ASX: HLS).
“Healius was a terrific stock we held through the pandemic,” said Bogdan.
“It was one of the few healthcare stocks [we held] because they’re a pathology company that benefited from PCR testing.”
The huge volume of COVID-19 testing saw a “100% uplift in profits” for Healius. But the Blackmore team feels like that pot of honey is running out.
“The company is reaching, sort of, peak earnings,” he said.
“So we’re taking advantage of the higher price that we’ve enjoyed.”
Bogdan’s team then reallocated the proceeds from that sale onto Atlas Arteria.
“By taking some profits out of Healius and putting it into Atlas, we’re actually increasing the overall dividend yield of the portfolio.”
The post Expert reveals the dividend ASX share he just bought (and one he dropped) appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- 5 things to watch on the ASX 200 on Friday
- Top brokers name 3 ASX dividend shares to buy today
- 2 blue chip ASX 200 shares to buy according to experts
Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/Jhl8v5f
Leave a Reply